Pharmatching

Critical Success Factors in Patient Safety Strategies

June 14 by Gabriele Dallmann

In this Pharma IQ interview Nabil Al-Tawil, Principal Investigator of the Phase I Unit at Karolinska University Hospital, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation...

Troubleshooting Biomarker Development Strategies

June 09 by Gabriele Dallmann

In this Pharma IQ interview Kristof Vercruysse, Director Clinical Operations at Ablynx, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, about innovation in phase I clinical developme...

How to Optimise Your Biomarker Development Strategies

May 23 by Kristof Vercruysse

Kristof Vercruysse, Director Clinical Operations at Ablynx, speaks to Dr. Gabriele Dallmann, CEO of Pharmatching GmbH about Innovation in phase 1 clinical development and optimisation of biomarker d...

FIND CONTENT BY TYPE

Pharma IQ COMMUNITY

ADVERTISE WITH US

Reach Pharmaceuticals & Biotechnology professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.

Advertise Now

JOIN THE Pharma IQ COMMUNITY

Join Pharma & Biotech today and interact with a vibrant network of professionals, keeping up to date with the industry by accessing our wealth of articles, videos, live conferences and more.

Pharma IQ, a division of IQPC

Careers With IQPC| Contact Us | About Us | Cookie Policy